Drugs / HTR2 T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06251544 | Jun 2026 → Jan 2029 expected | breast cancer | Baylor College of Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HTR2 T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06251544 ↗ |
| Known as | HTR2 cells | “HTR2 cells are generated from the patient's T cells and are frozen.” NCT06251544 ↗ |
| Action | Deplete | “Investigators now want to see if by putting a new gene in those T cells to help recognize breast cancer cells expressing HER2 can kill the cancer cells.” NCT06251544 ↗ |